2023 Q3 Form 10-Q Financial Statement

#000095017023037945 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $679.0M $714.0M
YoY Change 2.57% 2.73%
Cost Of Revenue $241.0M $245.0M
YoY Change 4.78% 12.9%
Gross Profit $438.0M $469.0M
YoY Change 1.39% -1.88%
Gross Profit Margin 64.51% 65.69%
Selling, General & Admin $269.0M $278.0M
YoY Change 1.13% 2.58%
% of Gross Profit 61.42% 59.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $65.00M $64.00M
YoY Change -2.99% -5.88%
% of Gross Profit 14.84% 13.65%
Operating Expenses $353.0M $364.0M
YoY Change 0.57% 1.96%
Operating Profit $85.00M $105.0M
YoY Change -7.61% -11.76%
Interest Expense $65.00M -$48.00M
YoY Change 6.56% -177.42%
% of Operating Profit 76.47% -45.71%
Other Income/Expense, Net $19.00M $22.00M
YoY Change 5.56% 22.22%
Pretax Income $31.00M -$143.0M
YoY Change -16.22% -192.26%
Income Tax $0.00 $3.000M
% Of Pretax Income 0.0%
Net Earnings $27.00M -$150.0M
YoY Change -22.86% -200.0%
Net Earnings / Revenue 3.98% -21.01%
Basic Earnings Per Share $0.13 -$0.70
Diluted Earnings Per Share $0.13 -$0.70
COMMON SHARES
Basic Shares Outstanding 215.7M 215.6M
Diluted Shares Outstanding 212.0M shares 215.0M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $726.0M $797.0M
YoY Change -25.23% 5.15%
Cash & Equivalents $726.0M $797.0M
Short-Term Investments
Other Short-Term Assets $63.00M $83.00M
YoY Change 57.5% 112.82%
Inventory
Prepaid Expenses
Receivables $149.0M $134.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $938.0M $1.014B
YoY Change -18.79% 7.19%
LONG-TERM ASSETS
Property, Plant & Equipment $8.028B $8.207B
YoY Change -3.18% -1.43%
Goodwill
YoY Change
Intangibles $42.00M $43.00M
YoY Change -2.33% 0.0%
Long-Term Investments
YoY Change
Other Assets $60.00M $45.00M
YoY Change 106.9% -61.21%
Total Long-Term Assets $8.367B $8.330B
YoY Change -3.06% -4.85%
TOTAL ASSETS
Total Short-Term Assets $938.0M $1.014B
Total Long-Term Assets $8.367B $8.330B
Total Assets $9.305B $9.344B
YoY Change -4.92% -3.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $293.0M $279.0M
YoY Change 15.35% 32.23%
Accrued Expenses $225.0M $228.0M
YoY Change -7.41% -7.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $654.0M $638.0M
YoY Change 5.48% 9.62%
LONG-TERM LIABILITIES
Long-Term Debt $4.490B $4.490B
YoY Change -3.85% -3.87%
Other Long-Term Liabilities $221.0M $203.0M
YoY Change 24.86% 21.56%
Total Long-Term Liabilities $4.711B $4.693B
YoY Change -2.81% -3.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $654.0M $638.0M
Total Long-Term Liabilities $4.711B $4.693B
Total Liabilities $5.365B $5.286B
YoY Change -1.87% -2.47%
SHAREHOLDERS EQUITY
Retained Earnings -$169.0M -$165.0M
YoY Change -544.74% -2850.0%
Common Stock $4.153B $4.223B
YoY Change -4.02% -2.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.984B $4.058B
YoY Change
Total Liabilities & Shareholders Equity $9.305B $9.344B
YoY Change -4.92% -3.68%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $27.00M -$150.0M
YoY Change -22.86% -200.0%
Depreciation, Depletion And Amortization $65.00M $64.00M
YoY Change -2.99% -5.88%
Cash From Operating Activities $127.0M $146.0M
YoY Change -14.19% -0.68%
INVESTING ACTIVITIES
Capital Expenditures $71.00M $70.00M
YoY Change -236.54% -325.81%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.000M
YoY Change -100.0% -99.5%
Cash From Investing Activities -$71.00M -$69.00M
YoY Change 914.29% -141.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -112.0M -110.0M
YoY Change 1300.0% -33.33%
NET CHANGE
Cash From Operating Activities 127.0M 146.0M
Cash From Investing Activities -71.00M -69.00M
Cash From Financing Activities -112.0M -110.0M
Net Change In Cash -56.00M -33.00M
YoY Change -142.11% -122.0%
FREE CASH FLOW
Cash From Operating Activities $127.0M $146.0M
Capital Expenditures $71.00M $70.00M
Free Cash Flow $56.00M $76.00M
YoY Change -72.0% -57.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001617406
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37795
dei Entity Registrant Name
EntityRegistrantName
Park Hotels & Resorts Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2058176
dei Entity Address Address Line1
EntityAddressAddressLine1
1775 Tysons Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Tysons
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22102
dei City Area Code
CityAreaCode
571
dei Local Phone Number
LocalPhoneNumber
302-5757
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
PK
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
215733384
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8002000000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8301000000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43000000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43000000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
797000000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
906000000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
45000000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
33000000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
134000000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
129000000
CY2023Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
83000000
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
58000000
CY2023Q2 us-gaap Other Assets
OtherAssets
35000000
CY2022Q4 us-gaap Other Assets
OtherAssets
47000000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
205000000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
214000000
CY2023Q2 us-gaap Assets
Assets
9344000000
CY2022Q4 us-gaap Assets
Assets
9731000000
CY2023Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4490000000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4617000000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
279000000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
220000000
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
131000000
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
141000000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
203000000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
228000000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
228000000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
234000000
CY2023Q2 us-gaap Liabilities
Liabilities
5331000000
CY2022Q4 us-gaap Liabilities
Liabilities
5440000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216425670
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215738036
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
224573858
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224061745
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2000000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4221000000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4321000000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165000000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16000000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4058000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4339000000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-45000000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-48000000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4013000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291000000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9344000000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9731000000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
714000000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
695000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1362000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1174000000
CY2023Q2 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
63000000
CY2022Q2 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
65000000
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
123000000
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
115000000
CY2023Q2 pk Management And Franchise Fees
ManagementAndFranchiseFees
34000000
CY2022Q2 pk Management And Franchise Fees
ManagementAndFranchiseFees
32000000
pk Management And Franchise Fees
ManagementAndFranchiseFees
64000000
pk Management And Franchise Fees
ManagementAndFranchiseFees
54000000
CY2023Q2 pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
203000000
CY2022Q2 pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
1000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
204000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
1000000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
68000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
128000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
137000000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16000000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32000000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
22000000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
18000000
us-gaap Other Expenses
OtherExpenses
42000000
us-gaap Other Expenses
OtherExpenses
34000000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
812000000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
575000000
us-gaap Costs And Expenses
CostsAndExpenses
1395000000
us-gaap Costs And Expenses
CostsAndExpenses
1053000000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-98000000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
119000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-18000000
us-gaap Operating Income Loss
OperatingIncomeLoss
120000000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
20000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000
CY2023Q2 us-gaap Interest Expense
InterestExpense
61000000
CY2022Q2 us-gaap Interest Expense
InterestExpense
62000000
us-gaap Interest Expense
InterestExpense
121000000
us-gaap Interest Expense
InterestExpense
124000000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97000000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143000000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
155000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99000000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-146000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
154000000
us-gaap Profit Loss
ProfitLoss
-113000000
us-gaap Profit Loss
ProfitLoss
98000000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5000000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-150000000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
150000000
us-gaap Net Income Loss
NetIncomeLoss
-117000000
us-gaap Net Income Loss
NetIncomeLoss
93000000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215000000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232000000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215000000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232000000
us-gaap Profit Loss
ProfitLoss
-113000000
us-gaap Profit Loss
ProfitLoss
98000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
128000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
137000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
204000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
1000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
93000000
us-gaap Share Based Compensation
ShareBasedCompensation
9000000
us-gaap Share Based Compensation
ShareBasedCompensation
9000000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4000000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6000000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7000000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-33000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-31000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
250000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
191000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52000000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11000000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
116000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
98000000
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
3000000
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
101000000
pk Contributions To Equity Method Investment
ContributionsToEquityMethodInvestment
4000000
pk Contributions To Equity Method Investment
ContributionsToEquityMethodInvestment
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
147000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
50000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
30000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
80000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
34000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3000000
us-gaap Payments Of Dividends
PaymentsOfDividends
88000000
us-gaap Payments Of Dividends
PaymentsOfDividends
2000000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1000000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4000000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
105000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
218000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-327000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-234000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-97000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
104000000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
939000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
763000000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
842000000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
867000000
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
32000000
CY2022Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
2000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291000000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
33000000
CY2023Q1 us-gaap Dividends
Dividends
32000000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
105000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4188000000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-146000000
CY2023Q2 us-gaap Dividends
Dividends
34000000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4013000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4403000000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-56000000
CY2022Q1 us-gaap Dividends
Dividends
2000000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
61000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4285000000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
154000000
CY2022Q2 us-gaap Dividends
Dividends
2000000
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4000000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
157000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4281000000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Interim results are not necessarily indicative of full year performance.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain line items on the audited condensed consolidated balance sheet as of December 31, 2022 have been reclassified to conform to the current period presentation.</span></p>
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15000000
CY2022Q2 pk Number Of Consolidated Hotel Portfolio Properties Sold
NumberOfConsolidatedHotelPortfolioPropertiesSold
3
CY2022Q2 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
102000000
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
92000000
CY2023Q2 us-gaap Land
Land
3196000000
CY2022Q4 us-gaap Land
Land
3317000000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6308000000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6512000000
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
965000000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
994000000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
229000000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
201000000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10698000000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11024000000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2696000000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2723000000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8002000000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8301000000
CY2023Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
64000000
CY2022Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
68000000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
128000000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
136000000
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-202000000
CY2023Q2 pk Number Of Consolidated Variable Interest Entities
NumberOfConsolidatedVariableInterestEntities
3
CY2023Q2 pk Number Of Unconsolidated Joint Ventures
NumberOfUnconsolidatedJointVentures
4
CY2022Q4 pk Number Of Unconsolidated Joint Ventures
NumberOfUnconsolidatedJointVentures
4
CY2023Q2 pk Unconsolidated Affiliate Debt
UnconsolidatedAffiliateDebt
721000000
CY2022Q4 pk Unconsolidated Affiliate Debt
UnconsolidatedAffiliateDebt
721000000
CY2023Q2 pk Longterm Debt And Financing Lease Obligations Gross
LongtermDebtAndFinancingLeaseObligationsGross
4514000000
CY2022Q4 pk Longterm Debt And Financing Lease Obligations Gross
LongtermDebtAndFinancingLeaseObligationsGross
4644000000
CY2023Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
1000000
CY2022Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
3000000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
25000000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
30000000
CY2023Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4490000000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4617000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
783000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
657000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1563000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
30000000
CY2023Q2 pk Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
1474000000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
4514000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1174000000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-146000000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
154000000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
29000000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7000000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7000000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
714000000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
695000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1362000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.480
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2023Q2 pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
-150000000
CY2022Q2 pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
150000000
pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
-117000000
pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
93000000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215000000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217000000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232000000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1000000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215000000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232000000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
us-gaap Profit Loss
ProfitLoss
-113000000
us-gaap Profit Loss
ProfitLoss
98000000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
68000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
128000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
137000000
CY2023Q2 pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
16000000
CY2022Q2 pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
16000000
pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
32000000
pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
32000000
CY2023Q2 pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
203000000
CY2022Q2 pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
1000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
204000000
pk Impairment And Casualty Loss
ImpairmentAndCasualtyLoss
1000000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
22000000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18000000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
42000000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
34000000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
20000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000
CY2023Q2 us-gaap Interest Expense
InterestExpense
61000000
CY2022Q2 us-gaap Interest Expense
InterestExpense
62000000
us-gaap Interest Expense
InterestExpense
121000000
us-gaap Interest Expense
InterestExpense
124000000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97000000
CY2023Q2 pk Other Items
OtherItems
-7000000
CY2022Q2 pk Other Items
OtherItems
-4000000
pk Other Items
OtherItems
-13000000
pk Other Items
OtherItems
-7000000
CY2023Q2 pk Adjusted Ebitda
AdjustedEbitda
192000000
CY2022Q2 pk Adjusted Ebitda
AdjustedEbitda
208000000
pk Adjusted Ebitda
AdjustedEbitda
344000000
pk Adjusted Ebitda
AdjustedEbitda
297000000
CY2023Q2 us-gaap Assets
Assets
9344000000
CY2022Q4 us-gaap Assets
Assets
9731000000
CY2023Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
163000000
CY2023Q2 us-gaap Litigation Reserve
LitigationReserve
8000000
pk Rule10 B51 Arr Adopted Flag
Rule10B51ArrAdoptedFlag
false
pk Non Rule10 B51 Arr Adopted Flag
NonRule10B51ArrAdoptedFlag
false
pk Rule10 B51 Arr Trmntd Flag
Rule10B51ArrTrmntdFlag
false
pk Non Rule10 B51 Arr Trmntd Flag
NonRule10B51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-037945-index-headers.html Edgar Link pending
0000950170-23-037945-index.html Edgar Link pending
0000950170-23-037945.txt Edgar Link pending
0000950170-23-037945-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pk-20230630.htm Edgar Link pending
pk-20230630.xsd Edgar Link pending
pk-ex31_1.htm Edgar Link pending
pk-ex31_2.htm Edgar Link pending
pk-ex32_1.htm Edgar Link pending
pk-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
pk-20230630_cal.xml Edgar Link unprocessable
pk-20230630_def.xml Edgar Link unprocessable
pk-20230630_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pk-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pk-20230630_pre.xml Edgar Link unprocessable